A cognitive-behavioral treatment package for depression in Parkinson's disease

Psychosomatics

Volumn 47, Issue 3, 2006, Pages 259-263

  Dobkin, Roseanne DeFronzo ^a   Allen, Lesley A ^a   Menza, Matthew ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; ESCITALOPRAM; MIRTAZAPINE; ROPINIROLE;

ADULT; AGED; ANAMNESIS; CAREGIVER; CASE REPORT; CLINICAL FEATURE; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG TOLERANCE; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; MALE; PARKINSON DISEASE; PRIMARY MEDICAL CARE; PSYCHOLOGIC ASSESSMENT; REVIEW; SOCIAL PSYCHOLOGY; SUICIDE ATTEMPT; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; ANXIETY DISORDER; ARTICLE; BEHAVIOR THERAPY; LEISURE; MAJOR DEPRESSION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; SLEEP DISORDER;

AGED; ANXIETY DISORDERS; BEHAVIOR THERAPY; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; RECURRENCE; RELAXATION; SLEEP DISORDERS;

EID: 33745239718     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.47.3.259     Document Type: Letter

References (26)

1. Jost WH: Costs in the treatment of parkinsonism. J Neurol 2000; 247(suppl4):31-33
2. Cummings JL: Depression and Parkinson's disease. Am J Psychiatry 1992; 149:443-454
3. Starkstein SE, Mayberg HS, Leiguarda R, et al: A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1992; 55:377-382
4. Brown RG, MacCarthy B, Gotham AM, et al: Depression and disability in Parkinson's disease: a follow-up of 132 cases. Psychol Med 1988; 18:49-55
5. Klaassen T, Verhey FR, Sneijders GH, et al: Treatment of depression in Parkinson's disease: a meta-analysis. J Neuropsychiatry Clin Neurosci 1995; 7:281-286
6. Zesiewicz TA, Gold M, Chari G, et al: Current issues in depression in Parkinson's disease. Am J Geriatr Psychiatry 1999; 7:110-118
7. Kostic VS, Stefanova E, Dragasevic N, et al: Diagnosis and treatment of depression in Parkinson's disease, in Mental and Behavioral Dysfunction in Movement Disorders. Edited by Bedard MA. Totowa, NJ, Humana Press, 2003, pp 351-368
8. Floyd M, Scogin F, McKendree-Smith N, et al: Cognitive therapy for depression: a comparison of individual psychotherapy and bibliotherapy for depressed older adults. Behav Modif 2004; 28:297-318
9. Azuma T, Cruz RF, Bayles KA, et al: A longitudinal study of neuropsychological change in individuals with Parkinson's disease. Int J Geriatr Psychiatry 2003; 18:1115-1120
10. Menza MA, Robertson-Hoffmann DE, Bonapace AS: Parkinson's disease and anxiety: comorbidity with depression. Biol Psychiatry 1993; 34:465-470
11. Whetten-Goldstein K, Sloan F, Kulas E, et al: The burden of Parkinson's disease on society, family, and the individual. J Am Geriatr Soc 1997; 45:844-849
12. Beck AT, Rush AJ, Shaw BF, et al: Cognitive Therapy of Depression. New York, Guilford, 1979
13. DeRubeis RJ, Beck AT: Cognitive therapy, in Handbook of Cognitive-Behavioral Therapies. Edited by Dobson K. New York, Guilford, 1988, pp 273-306
14. Wade DT: Measurement in Neurological Rehabilitation. New York, Oxford University Press, 1992, pp 324-325
15. Hamilton MA: Rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
16. Alloy LB, Abramson LY: The Temple-Wisconsin Cognitive Vulnerability to Depression (CVD) Project: conceptual background, design, and methods. J Cogn Psychother 1999; 13:227-262
17. Speilberger CD, Gorsuch RL, Lushene RE: STAI Manual for the State-Trait Anxiety Inventory. Palo Alto, CA, Consulting Psychologists Press, 1970
18. Dobkin RD, Panzarella C, Fernandez J, et al: Adaptive inferential feedback, depressogenic inferences, and depressed mood: a laboratory study of the expanded hopelessness theory of depression. Cogn Therapy Res 2004; 28:487-509
19. Henderson R, Kurlan R, Kersun JM, et al: Preliminary examination of the comorbidity of anxiety and depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992; 4:257-264
20. DeFronzo R, Panzarella C, Butler AC: Attachment, support-seeking, and adaptive inferential feedback: implications for psychological health. Cognitive Behavioral Practice 2001; 8:48-52
21. Beck AT, Steer RA, Garbin MG: Psychometric properties of the Beck Depression Inventory: 25 years of evaluation. Clin Psychol Rev 1988; 8:77-100
22. Leentjens AF, Verhey FR, Luijckx GJ, et al: The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease. Mov Disord 2000; 15:1221-1224
23. Frank E, Prien RF, Jarrett RB, et al: Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Arch Gen Psychiatry 1991; 48:851-855
24. Hollon SD, Jarrett RB, Nierenberg AA, et al: Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J Clin Psychiatry 2005; 66:455-468
25. Thase ME, Friedman ES, Howland RH: Management of treatment-resistant depression: psychotherapeutic perspectives. J Clin Psychiatry 2001; 62:18-24
26. DeRubeis RJ, Hollon SD, Amsterdam JD, et al: Cognitive therapy vs. medications in the treatment of moderate-to-severe depression. Arch Gen Psychiatry 2005; 62:409-416